Literature DB >> 19505535

A systems biology view of cancer.

Reinhard Laubenbacher1, Valerie Hower, Abdul Jarrah, Suzy V Torti, Vladimir Shulaev, Pedro Mendes, Frank M Torti, Steven Akman.   

Abstract

In order to understand how a cancer cell is functionally different from a normal cell it is necessary to assess the complex network of pathways involving gene regulation, signaling, and cell metabolism, and the alterations in its dynamics caused by the several different types of mutations leading to malignancy. Since the network is typically complex, with multiple connections between pathways and important feedback loops, it is crucial to represent it in the form of a computational model that can be used for a rigorous analysis. This is the approach of systems biology, made possible by new -omics data generation technologies. The goal of this review is to illustrate this approach and its utility for our understanding of cancer. After a discussion of recent progress using a network-centric approach, three case studies related to diagnostics, therapy, and drug development are presented in detail. They focus on breast cancer, B-cell lymphomas, and colorectal cancer. The discussion is centered on key mathematical and computational tools common to a systems biology approach.

Entities:  

Mesh:

Year:  2009        PMID: 19505535      PMCID: PMC2782452          DOI: 10.1016/j.bbcan.2009.06.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  66 in total

1.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

2.  A computational algebra approach to the reverse engineering of gene regulatory networks.

Authors:  Reinhard Laubenbacher; Brandilyn Stigler
Journal:  J Theor Biol       Date:  2004-08-21       Impact factor: 2.691

3.  Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

Authors:  S R Datta; H Dudek; X Tao; S Masters; H Fu; Y Gotoh; M E Greenberg
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

4.  Induction of NF-kappaB by the Akt/PKB kinase.

Authors:  L P Kane; V S Shapiro; D Stokoe; A Weiss
Journal:  Curr Biol       Date:  1999-06-03       Impact factor: 10.834

5.  Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation.

Authors:  P Rodriguez-Viciana; P H Warne; B Vanhaesebroeck; M D Waterfield; J Downward
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

6.  Quantification of short term signaling by the epidermal growth factor receptor.

Authors:  B N Kholodenko; O V Demin; G Moehren; J B Hoek
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

Review 7.  Cancer genes and the pathways they control.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

8.  Regulation of cell death protease caspase-9 by phosphorylation.

Authors:  M H Cardone; N Roy; H R Stennicke; G S Salvesen; T F Franke; E Stanbridge; S Frisch; J C Reed
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

9.  Gene expression in primate liver during viral hemorrhagic fever.

Authors:  Mahmoud Djavani; Oswald R Crasta; Yan Zhang; Juan Carlos Zapata; Bruno Sobral; Melissa G Lechner; Joseph Bryant; Harry Davis; Maria S Salvato
Journal:  Virol J       Date:  2009-02-12       Impact factor: 4.099

10.  Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: identification of the c-myc regulatory gene network.

Authors:  Susanne Reymann; Jürgen Borlak
Journal:  BMC Syst Biol       Date:  2008-05-22
View more
  32 in total

1.  The Study of Apoptosis-inducing Effects of Three Pre-apoptotic Factors by Gallic Acid, Using Simulation Analysis and the Comet Assay Technique on the Prostatic Cancer Cell Line PC3.

Authors:  Javad Saffari-Chaleshtori; Ehsan Heidari-Sureshjani; Fahimeh Moradi; Hojjatollah Molavian Jazi; Esfandiar Heidarian
Journal:  Malays J Med Sci       Date:  2017-08-18

Review 2.  Systems biology for molecular life sciences and its impact in biomedicine.

Authors:  Miguel Ángel Medina
Journal:  Cell Mol Life Sci       Date:  2012-08-19       Impact factor: 9.261

Review 3.  The emerging paradigm of network medicine in the study of human disease.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  Circ Res       Date:  2012-07-20       Impact factor: 17.367

Review 4.  Systems biology and cancer: promises and perils.

Authors:  Stuart G Baker; Barnett S Kramer
Journal:  Prog Biophys Mol Biol       Date:  2011-03-23       Impact factor: 3.667

5.  Diagnostic assessment of osteosarcoma chemoresistance based on Virtual Clinical Trials.

Authors:  K A Rejniak; M C Lloyd; D R Reed; M M Bui
Journal:  Med Hypotheses       Date:  2015-06-24       Impact factor: 1.538

6.  Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms.

Authors:  Stacey D Finley; Aleksander S Popel
Journal:  AAPS J       Date:  2012-05-01       Impact factor: 4.009

Review 7.  Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.

Authors:  L Ouyang; Z Shi; S Zhao; F-T Wang; T-T Zhou; B Liu; J-K Bao
Journal:  Cell Prolif       Date:  2012-10-03       Impact factor: 6.831

Review 8.  A systems biology approach to iron metabolism.

Authors:  Julia Chifman; Reinhard Laubenbacher; Suzy V Torti
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 9.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

10.  Proteomics, pathway array and signaling network-based medicine in cancer.

Authors:  David Y Zhang; Fei Ye; Ling Gao; Xiaoliang Liu; Xin Zhao; Yufang Che; Hongxia Wang; Libo Wang; Josephine Wu; Dong Song; Wei Liu; Hong Xu; Bo Jiang; Weijia Zhang; Jinhua Wang; Peng Lee
Journal:  Cell Div       Date:  2009-10-28       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.